PTX 0.00% 4.1¢ prescient therapeutics limited

Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2 Posts.
    lightbulb Created with Sketch. 4
    Looks like FDA is already bullish on PTX-100 - "granting broader designation than Prescient requested". Bodes well for its chances on getting on the Accelerated Approval Program this year that SYC alluded to - all eyes on the update of the Phase1b study.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.1¢ 4.2¢ 4.1¢ $7.275K 175.2K

Buyers (Bids)

No. Vol. Price($)
9 720577 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 148571 2
View Market Depth
Last trade - 15.46pm 01/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.